CRNX
Crinetics Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$84.95
+0.00%0
Insider buys (3m)
3
Insider sells (3m)
-$366.1K
Net value (3m)
+146.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 24, 2026 | Schilke Tobin · officer: Chief Financial & Infra. Ofcr. | A-Award | 471 | $0.00 |
| Aug 11, 2026 | Struthers Richard Scott · director, officer: President & CEO | M-Exempt | 6,542 | $15 |
| Aug 11, 2026 | Struthers Richard Scott · director, officer: President & CEO | M-Exempt | 4,422 | $23 |
| Aug 11, 2026 | Struthers Richard Scott · director, officer: President & CEO | M-Exempt | 3,969 | $25 |
| Aug 11, 2026 | Struthers Richard Scott · director, officer: President & CEO | M-Exempt | 4,995 | $20 |
| Jul 7, 2026 | Vivaldi Coelho Rogerio · director | Sale | 3,000 | $40 |
| Jun 22, 2026 | Nichols Weston · director | A-Award | 9,730 | $36 |
| Jun 22, 2026 | Okey Stephanie · director | A-Award | 5,925 | $0.00 |
| Jun 22, 2026 | Fust Matthew K · director | A-Award | 5,925 | $0.00 |
| Jun 22, 2026 | Vivaldi Coelho Rogerio · director | A-Award | 5,925 | $0.00 |
| Jun 22, 2026 | Bedrosian Camille L · director | A-Award | 9,730 | $36 |
| Jun 22, 2026 | Bedrosian Camille L · director | A-Award | 5,925 | $0.00 |
| Jun 22, 2026 | Nichols Weston · director | A-Award | 5,925 | $0.00 |
| Jun 22, 2026 | Vivaldi Coelho Rogerio · director | A-Award | 9,730 | $36 |
| Jun 22, 2026 | WIERENGA WENDELL · director | A-Award | 9,730 | $36 |
| Jun 22, 2026 | Okey Stephanie · director | A-Award | 9,730 | $36 |
| Jun 22, 2026 | Deardorf Caren · director | A-Award | 5,925 | $0.00 |
| Jun 22, 2026 | Deardorf Caren · director | A-Award | 9,730 | $36 |
| Jun 22, 2026 | WIERENGA WENDELL · director | A-Award | 5,925 | $0.00 |
| Jun 22, 2026 | Fust Matthew K · director | A-Award | 9,730 | $36 |
| Jun 18, 2026 | Okey Stephanie · director | Sale | 608 | $36 |
| Jun 18, 2026 | Okey Stephanie · director | Sale | 6,292 | $36 |
| Apr 10, 2026 | Knight Jeff E. · officer: Chief Dev. & Operating Officer | M-Exempt | 9,624 | $20 |
| Apr 10, 2026 | Knight Jeff E. · officer: Chief Dev. & Operating Officer | M-Exempt | 49,474 | $24 |
| Apr 10, 2026 | Knight Jeff E. · officer: Chief Dev. & Operating Officer | M-Exempt | 19,336 | $20 |
| Apr 10, 2026 | Knight Jeff E. · officer: Chief Dev. & Operating Officer | Sale | 85,163 | $40 |
| Mar 13, 2026 | Vivaldi Coelho Rogerio · director | Sale | 523 | $37 |
| Mar 13, 2026 | Vivaldi Coelho Rogerio · director | Sale | 4,477 | $36 |
| Mar 4, 2026 | Okey Stephanie · director | Sale | 3,000 | $40 |
| Mar 4, 2026 | Schilke Tobin · officer: Chief Financial Officer | Sale | 6,713 | $40 |
Institutional positioning
13F filings over the trailing two quarters
New 105Increased 214Reduced 137Sold out 33
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 15,840,219 | Aug 13, 2026 |
| FMR LLC | Increased | 15,759,799 | May 15, 2026 |
| BlackRock, Inc. | Increased | 9,758,938 | Aug 7, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Increased | 8,989,098 | Aug 14, 2026 |
| BLACKROCK, INC. | Increased | 8,478,815 | May 13, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Increased | 8,338,098 | May 15, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 8,157,204 | May 15, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 7,131,084 | Aug 14, 2026 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Increased | 6,463,551 | Aug 14, 2026 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Increased | 6,395,922 | May 15, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 6,212,681 | Aug 14, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 5,355,496 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 4,832,614 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 4,745,262 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 4,673,935 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 24, 2026